Online pharmaceutical brands Hims & Hers are introducing a weight-loss drug containing a compounded form of semaglutide, the active ingredient…
Its stock jumped nearly 30% on the news.…
Hims & Hers compounded GLP-1 — the same ingredient as Ozempic — will be priced at $200 a month. Investors…
Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections as Ozempic and Wegovy soar in popularity.…
…
The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of…
These are the stocks posting the largest moves in midday trading.…
These are the stocks posting the largest moves in midday trading.…
It was a huge day for Hims Hers Health (NASDAQ:HIMS) as the online pharmacy opened up a new product…
Hims & Hers Health Inc shares rocketed 31% higher on Monday after announcing it will provide access to injectable GLP-1…
Hims & Hers Health expands its weight loss offerings with GLP-1 injections and oral medication kits. Pricing starts at $79/month.…
In just a few years, Hims and Hers Health Inc. reached almost $1 billion in sales by making it easy…
The telehealth companys stock surged after the announcement Monday…
Hims & Hers Health (NYSE: HIMS) stock price is doing well, helped by its strong growth and demand for its…
Read about the markets top gainers and losers, including Hims & Hers Health and Blue Star Foods.…
Hims & Hers Health offers cheap access to compounded versions of semaglutide, a weight loss medication, aiming to save consumers…
Wegovy, made by Novo Nordisk A/S, costs roughly $1,350 for a month of injections without insurance, and Eli Lilly &…
The GLP-1 market has faced supply constraints in recent months as drugs like Ozempic and Wegovy continue to skyrocket in…
The GLP-1 market has faced supply constraints in recent months as the drugs like Ozempic and Wegovy skyrocket in popularity.…
Six months after launching its weight loss program, online health and wellness company Hims & Hers added compounded GLP-1 medications…
Tech sector gains helped power the Nasdaq to a record intraday high on Monday, May 20, 2024, while the S&P…
The case for the overvalued Hims & Hers stock…
Hims & Hers (HIMS) stock is soaring after the healthcare platform added weight-loss injections…
Forerunner Ventures Management LLC purchased a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free…
Baader Bank Aktiengesellschaft trimmed its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 38.9% in…
Russell Investments Group Ltd. increased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by…
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) was the target of a significant increase in short interest…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of a large increase in short interest…
Hims & Hers Health (NYSE:HIMS – Get Free Report) and Auna (NYSE:AUNA – Get Free Report) are both medical companies,…
Anja Manuel appointed to Hims & Hers board…
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and…
SAN FRANCISCO--(BUSINESS WIRE)--May 16, 2024--…
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is…
Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated…